<DOC>
	<DOCNO>NCT01044095</DOCNO>
	<brief_summary>This randomize , open-label , pilot feasibility study four 2-dose vaccine regimens healthy volunteer use two commercially available seasonal influenza vaccine compare immune response vitro cross-reactivity H5N1 . Vaccine dose space approximately 8 week allow optimal prime boost condition . Humoral , cellular secretory immune response measure 2 4 week vaccine dose compare baseline value .</brief_summary>
	<brief_title>Study Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Influenza Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Aged 1849 year . 2 . Healthy determine PI designate 3 . Willing give inform consent . 4 . Willing attend followup appointment undergo study procedure . 5 . US passport holder reside Bangkok 6 . If military , letter approval participation chain command ( Unit Commander ) . 1 . History hypersensitivity egg , egg protein , gentamicin , gelatin arginine . 2 . Severe lifethreatening reaction previous vaccine . 3 . History chronic respiratory illness , include asthma sinusitis . 4 . History heart disease 5 . History kidney disease 6 . Metabolic disease diabetes 7 . Immunocompromised determined PI , household contact immunocompromised individual . 8 . History GuillainBarre syndrome . 9 . Blood disease include sickle cell disease and/or bleeding tendency ( history base medical record ) . 10 . Any influenza vaccination within previous 6 month , vaccine within 30 day either dose influenza vaccine . 11 . Pregnant woman nurse mother unwilling use reliable contraception study period final day followup . 12 . Blood donation within precede 3 month , screen hemoglobin value &lt; 12.5 g/dl . 13 . Receipt blood product include immunoglobulin within precede 3 month . 14 . Receiving follow therapy : aspirin , warfarin , theophylline , phenytoin , aminopyrine , immunosuppressive drug , 15 . Receipt antiviral agent within 48 hour vaccine administration . 16 . HIV positive screening blood test . 17 . Any condition opinion study investigator warrant exclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>seasonal influenza vaccine</keyword>
	<keyword>avian influenza H5N1</keyword>
	<keyword>cross reactivity</keyword>
	<keyword>prime boost</keyword>
</DOC>